Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options / PDMR dealing

16 Feb 2017 07:00

RNS Number : 0147X
Sopheon PLC
16 February 2017
 

 

 

SOPHEON PLC

("Sopheon" or "the Company")

 

Grant of Options / PDMR dealing

 

Sopheon announces that the Company has granted 36,650 options over ordinary shares of 20 pence each in the share capital of the Company ("Options") to certain directors. These grants are part of a wider option grant of 163,900 Options, to certain key executives and departmental managers of the Company. Of the directors, Andrew Michuda has been granted 25,000 Options, and Arif Karimjee has been granted 11,650 Options.

 

The Options granted will vest over 3 years, and are exercisable up to 10 years from the date of grant. The exercise price of the Options is 467.5 pence per share, being the mid-market closing price on AIM on 15 February 2017.

 

Following this grant, Andrew Michuda has 240,000 Options in total, and Arif Karimjee has 75,000 Options. In addition, Andrew Michuda and Arif Karimjee respectively own 30,000 and 50,000 ordinary shares of the Company, and they (or persons connected with them) are respectively invested in £45,000 and £27,000 of the Company's convertible loan stock.

 

 

For further information contact: 

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (corporate finance)

Mia Gardener (corporate broking)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Arif Karimjee

2.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 467.5 pence per share

11,650

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 11,650 options over ordinary shares of 20p pence at an exercise price of 467.5 pence

e)

Date of the transaction

16 February 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Michuda

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

n/a

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise Price 467.5 pence per share

25,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 25,000 options over ordinary shares of 20p pence at an exercise price of 467.5 pence

e)

Date of the transaction

16 February 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSOKPDPOBKDOBD
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.